コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
2 t, the mean decay constant was 0.29 +/- 0.09 min-1, equivalent to a half-life of approximately 2.4 mi
3 CBS device with analysis times as short as 1 min per sample when 96 extractions are simultaneously co
4 only 1 muL of sample in a fast (less than 1 min per sample) and high-throughput (up to 384 samples p
8 HR achieved minus the HR at: 30-s (HRR30), 1-min (HRR1), 2-min (HRR2), 3-min (HRR3), 4-min (HRR4) or
11 every minute for 20 min during and after 10 min systemic hyperoxia; and on day 3, electroretinograph
12 W) powers of 180, 360 and 540 W for 5 and 10 min were evaluated for their influence on oil yield, che
15 Bacteria were automatically mixed for 10 min with serially diluted antibiotics with a novel, memb
17 quipment failure; and treatment duration >10 min), a battery-operated thermal ablator that is lightwe
18 fects of analogous PEMF exposure (1.5 mT, 10 min/week), with and without exercise, on systemic metabo
21 All experiments detected mcr-9 in under 10 min, and both platforms showed no statistically signific
22 d 5-log reduction for both strains within 10 min in most scenarios, except for TLF thicker than 0.6 m
23 dependence of I(Na) inactivation (within 10 min) and subsequent superimposed positive activation and
28 n), followed by the BS-Cat (123.81 +/- 30.11 min) and BT-Cat groups (186.00 +/- 42.34 min; P < .001),
29 was shortest in the US-Cat (91.62 +/- 26.12 min), followed by the BS-Cat (123.81 +/- 30.11 min) and
30 ere, high-throughput growth, completed in 12 min, of 6-inch wafer-scale monolayer MoS(2) and WS(2) is
32 ow metabolism in blood (69% of parent at 120 min), a high plasma free fraction of 38.5%, and a suitab
38 AA content decreased very quickly and at 14 min (203-205 degrees C) its concentration was lower than
41 s off the east coast of Costa Rica for 83.15 min (+/- 9.12 SD) to determine their movements and swimm
42 duration of time (which can be capped at 15 min) until the experimenter returns so that they can rec
44 ore, the method is quick (analysis time <=15 min), requires low-cost instrumentation and sensor chips
47 89)Zr-DFO-azepin-onartuzumab in less than 15 min, with an isolated decay-corrected radiochemical yiel
48 ibiotic susceptibility of bacteria within 15 min, which is a significant advantage over existing tech
50 response was ~0.1 mg/L (detected in just 16 min), while changes in different metabolites suggest a c
52 ing the first (10-80 min) and second (90-160 min) hyperglycemic clamp steps increased by 3.8-fold and
53 procedure time was 125 min (IQR: 108 to 166 min) (including a median of 28 min [IQR: 25 to 33 min] f
55 % CI): 4266 (261, 8270) mumol.min-1.kg-1.180 min; P = 0.04; eta2p = 0.31] and branched-chain amino ac
57 counting rate within 10-20 trials (under 1-2 min of testing), captured approximately 10% more varianc
59 (CPB) time (146.9 +/- 40.6 vs 189.6 +/- 41.2 min for DHCA; p < 0.05) and higher nasopharyngeal temper
60 cytometry; fast association/dissociation (~2 min)] revealed 26 as a useful molecular tool to determin
62 trations were quantified accurately within 2 min in the full breath-relevant range (10-1000 ppm) in e
63 ate and during a two-step (10 and 20 mU/m(2)/min) hyperinsulinemic-euglycemic clamp with stable isoto
64 nus the HR at: 30-s (HRR30), 1-min (HRR1), 2-min (HRR2), 3-min (HRR3), 4-min (HRR4) or 5-min (HRR5) o
65 0 and 220 degrees C, during 9, 12, 15 and 20 min, and characterized in relation to color change, oxal
66 heat-induced oil isolation (90 degrees C/20 min), but pH-shift-produced oils had higher amounts of n
67 blood flow was measured every minute for 20 min during and after 10 min systemic hyperoxia; and on d
75 drug to have diabetes, respiratory rate >22/min, abnormal chest imaging findings, O2 saturation lowe
77 d at 5, 10, 20, 30, 40, 50, 60, 120, and 240 min after (18)F-FDG administration (370 +/- 16 MBq).
78 and increased standing times of 120 and 240 min with accuracies ranging from 85.5 to 88.0%, because
79 tandardised digestion protocol from 0 to 240 min and subsequently analysed by SDS-PAGE, quantitative
80 uisitions at scheduled time points up to 248 min after the administration of (18)F-rhPSMA-7.3 (mean a
81 ame later by ~50 min during weekdays and ~25 min on weekends, and thus the difference between weekend
85 e with a sensitivity of 100 copies within 25 min and generated stronger specific fluorescence signals
86 n be prepared at the point-of-care within 26 min using fresh blood, it can be easily delivered using
87 R: 108 to 166 min) (including a median of 28 min [IQR: 25 to 33 min] for voltage mapping), with a med
89 d usage of short (median 7.4, range 4.1-20.3 min) and long (median 17.2, range 6.1-47.7 min) video fo
90 ssed every 20 s for 6 min during and after 3 min flicker light (12 Hz) stimulation; on day 2, retinal
94 30-s (HRR30), 1-min (HRR1), 2-min (HRR2), 3-min (HRR3), 4-min (HRR4) or 5-min (HRR5) of recovery.
95 ween the results of the nuc-aAST after 15-30 min of antibiotic exposure and the results of the gold-s
97 Pancreas SUV ratio minus 1 (SUVR-1) (20-30 min; spleen as reference region) demonstrated a statisti
98 tivities of lipase and lipoxygenase after 30 min steam autoclaving were 6.25% and 18.60%, respectivel
99 lved i.e. three soaking times (0, 15, and 30 min), three temperatures (20, 25, and 30 degrees C) and
101 bacteria heat inactivation (99 degrees C/30 min), and enrichment for mycobacteria DNA were achieved
102 in extraction, rapid enzymatic digestion (30 min compared to overnight), and subsequent MS-analysis f
104 oaked in 10 mg/L of carbaryl solution for 30 min and then washed for 30 min in one of the five washin
107 l solution for 30 min and then washed for 30 min in one of the five washing solutions and the results
108 ted enzyme caused 1 pH unit difference in 30 min, with an initial rate of 0.35 pH.min(-1) To understa
109 ngendorff preparation were exposed to IR (30 min ischaemia) after 4 treatments administered randomly,
111 ective of this work was to enable rapid (<30 min), sensitive (>100-fold improvement), and high-throug
112 d >1 h to access motorised boreholes but <30 min, increasing to 30-60 mins, for hand-pumped boreholes
113 ith an optimal analytical performance of ~30 min, the resulting bacterial detection platform was demo
114 id bolus (10mL/kg of Ringers-Lactate over 30 min) for management of shock and/or hypoperfusion within
115 eep deprivation than after normal sleep: (30 min [interquartile range [IQR], 17-41] vs. 60 min [IQR,
116 pedance changes are recorded in less than 30 min, in comparison with >8 h in the best alternative rep
117 eved ~100 copies/muL sensitivity in under 30 min of measurement time and accurately detected pre-extr
122 nly K (1) was reproducible from truncated 30-min datasets (intraclass correlation coefficient, 0.96).
125 (including a median of 28 min [IQR: 25 to 33 min] for voltage mapping), with a median of 16 min (IQR:
126 .11 min) and BT-Cat groups (186.00 +/- 42.34 min; P < .001), contrary to the duration of surgery (US-
129 elivers sensor response to raw fish within 4 min, reflecting its freshness status in comparison to th
130 , and one commercial enzyme (on average 0.4%/min), while all exogenous enzymes were able to hydrolyse
137 ed cold pressor pain tolerance before and 40-min after double-blind injection of .08 mg/kg morphine o
144 Increased antioxidant activities at 3 and 5 min of blanching varied with the type of fruit peelings.
148 00 mg/m(2) administered intravenously over 5 min, followed by a 46 h infusion of fluorouracil 2400 mg
152 for LMG detection can be completed within 5 min without any incubation, washing and blocking steps.
153 CFU reductions observed as early as within 5 min, and in vivo by causing structural damage due to sal
157 estigated the effect of roasting time (10-50 min) and temperature (110-160 degrees C) on the potentia
159 degrees C or 180 degrees C up to 119 and 50 min, respectively; commercial soybean oil (SO) was teste
166 ance (strength phenotype; 17 proteins) and 6 min walk performance (endurance phenotype; 17 proteins)
167 nal blood flow was assessed every 20 s for 6 min during and after 3 min flicker light (12 Hz) stimula
171 Here, we exposed wild-type male mice to 5-60 min of 40 Hz or control flicker and assessed cytokine an
172 es, were lower in the MHD group at 30 and 60 min post meal ingestion compared to controls (P < 0.05).
176 imic DCD, pig kidneys underwent 0, 30, or 60 min of warm ischemia, before hypothermic machine perfusi
177 scanned by dynamic (18)F-FDG PET/CT over 60 min, and quantified images were compared with those acqu
179 r radioactivity that plateaued from 40 to 60 min and was significantly reduced by pretreatment with k
182 GA were as follows: an incubation time of 64 min, incubation temperature of 32 degrees C, and enzyme
183 duration of surgery (US-Cat: 37.56 +/- 15.69 min; BS-Cat: 32.33 +/- 17.31 min; BT-Cat: 37.50 +/- 18.6
186 ement times were 5(IQR: 4-6) and 6(IQR: 5-7) min, mild adverse events occurred in 4(9.4%) and 4(14.2%
190 rtile range [IQR]: 38-71) and 60(IQR: 48-77) min, median LP placement times were 5(IQR: 4-6) and 6(IQ
191 in was greater (P < 0.05) by actinidin (0.8%/min) when compared to papain, bromelain, and one commerc
192 se insulin secretion during the first (10-80 min) and second (90-160 min) hyperglycemic clamp steps i
196 provide a balance between scans at 60 and 90 min of uptake, parameters compliant and noncompliant wit
200 kemia underwent whole-body PET/CT imaging 90 min after injection of (18)F-SKI (mean, 241.24 +/- 116.3
202 The SUVR-1 of (18)F-SynVesT-1 from 60 to 90 min matched best with 1TC BP (ND) Conclusion: The novel
206 eeks: sustained AFL; sustained AF (600 beats/min atrial tachypacing); AF superimposed on an AFL subst
207 Over a mean of 182.6 (88.6) follow-up days (min-max: 0-364 days), 22 TEAEs were reported by 7 (2.8%)
209 .47, 9.60 kcal), faster eating rates (0.40 g/min; 0.21, 0.59 g/min), and larger lunch intakes (7.05 k
210 aster eating rates (0.40 g/min; 0.21, 0.59 g/min), and larger lunch intakes (7.05 kcal; 3.37, 10.74 k
214 flozin was 22% greater (+0.66 +/- 0.11 mg/kg/min, P < 0.05) than in subjects receiving placebo, and i
215 ak Vo(2) (13.1+/-3.4 versus 22.7+/-4.0 mL/kg/min; P<0.001) and heart rate (122+/-20 versus 155+/-14 b
216 wever, when infusion rates exceeded 20 ul/kg/min, signs of injury occurred at pressures from 0.39 to
219 igher than in the pulmonary arteries (0.15 L/min +/- 0.10) and descending aorta and superior vena cav
220 th in patients with supplemental oxygen >2 L/min at diagnosis was 6.18 ([1.33, 26.83], P = 0.02).
221 e of oxygen supplementation of more than 4 L/min flow; use of high-flow nasal cannula; use of non-inv
222 viation of cardiac output in the aAo (0.58 L/min +/- 0.45) was significantly (P < .001) higher than i
224 usion was similar (Fontan = 2.50 +/- 1.02 ml min(-1) ml(-1) ; Fontan control = 3.09 +/- 0.58, PAH = 3
225 re not different (Fontan = -0.23 +/- 0.09 ml min(-1) ml(-1) cm(-1) ; Fontan control = -0.29 +/- 0.23,
227 aCl(2) : -1 +/- 17 vs. control: 30 +/- 28 ml min(-1) 100 mmHg(-1) ; n = 9; P = 0.004) and attenuated
231 oth rest (mean difference: -0.034+/-0.035 mL.min(-1).cc(-1), limits of agreement: [-0.103 to 0.035] m
232 ), limits of agreement: [-0.103 to 0.035] mL.min(-1).cc(-1)) and stress (mean difference: 0.057+/-0.3
233 nd stress (mean difference: 0.057+/-0.361 mL.min(-1).cc(-1), limits of agreement: [-0.651 to 0.765] m
234 estimated glomerular filtration rate <60 mL.min(-1).1.73 m(-2), albuminuria, and diuretic use (each
236 earance calculated on POD3 (63.6 +/- 19.0 mL/min) compared with HAMP (13.5 +/- 10.3 mL/min, P = 0.001
238 /- 0.59, P = .94) and mean rest MBF (1.08 mL/min/g +/- 0.23 vs 1.07 mL/min/g +/- 0.23, P = .83).
239 3 m(2) (interquartile range: 30.9 to 60.1 ml/min/1.73 m(2)), and was <60 ml/min/1.73 m(2) in 74.9% of
241 s (in 39 patients) with eGFR less than 15 mL/min/1.73 m(2), and 34 examinations in 27 patients underg
243 flow (MBF; 2.25 mL/min/g +/- 0.59 vs 2.24 mL/min/g +/- 0.59, P = .94) and mean rest MBF (1.08 mL/min/
244 n stress myocardial blood flow (MBF; 2.25 mL/min/g +/- 0.59 vs 2.24 mL/min/g +/- 0.59, P = .94) and m
245 tions (in 94 patients) with eGFR of 15-29 mL/min/1.73 m(2), 40 examinations (in 39 patients) with eGF
246 mL/min) compared with HAMP (13.5 +/- 10.3 mL/min, P = 0.001) and SCS (4.0 +/- 2.6 mL/min, P = 0.001).
247 mated glomerular filtration rate was 42.3 ml/min/1.73 m2, and median urine albumin-to-creatinine rati
249 estimated glomerular filtration rate < 30 mL/min or graft loss at 1 y, n = 66) were analyzed by using
250 than 80%, or a creatinine clearance of 30 mL/min or more but less than 60 mL/min, or those who refuse
251 (estimated glomerular filtration rate <30 mL/min per 1.73 m(2)) from the Swedish Heart Failure Regist
252 ears, 36% female) with new-onset eGFR <30 ml/min per 1.73 m(2), 1553 (15%) stopped RAS inhibitor ther
253 estimated glomerular filtration rates <30 mL/min who received >=5 days of ceftaroline, 3 developed en
254 out severe renal (creatine clearance <=30 mL/min) or liver disease were included in this analysis (n=
257 lomerular filtration rate (eGFR) 59 to 30 mL/min/1.73 m2 on two consecutive previous blood tests were
259 years; postnephrectomy baseline eGFR, 48 ml/min per 1.73 m(2)), 117 progressive CKD events, 183 nonc
261 e not clinically important (56.6 vs. 57.5 mL/min/1.73m for ideal comparator kidneys; p < 0.001).
264 cident CKD (stage 3 or higher) as eGFR<60 ml/min per 1.73 m(2) and >=25% decline from baseline, CKD-r
266 come (>=40% decline in eGFR, with eGFR<60 ml/min per 1.73 m(2), or ESKD), and linear mixed models for
270 AKI with eGFR greater than or equal to 60 mL/min/1.73 m(2) was 2.2% (20 of 889) for CT and US (odds r
271 usted P = .95) and with eGFR less than 60 mL/min/1.73 m(2) was 5.6% (two of 36) and 11.1% (four of 36
276 lomerular filtration rate (eGFR) was 43.7 ml/min/1.73 m(2) (interquartile range: 30.9 to 60.1 ml/min/
277 +/- SD 87.4 +/- 23.9 versus 80.1 +/- 20.7 mL/min/1.73 m(2); p < 0.0001), while CD had more severe May
278 normal kidney function (eGFR 84 +/- 11.7 ml/min/1.73m(2)) and norm-albuminuria at baseline, UPPod:CR
279 3 increased blood flow at rest (79 +/- 87 ml/min; P = 0.03) and augmented the exercise-induced hypera
282 d model, factors associated with eGFR <90 mL/min/1.73 m2 included white race, older age, higher body
283 58 years (IQR, 52-65), median eGFR was 95 ml/min per 1.73 m(2) (IQR, 74-100) using the CKD-EPI formul
285 stimated glomerular filtration rate >=15 mL/(min.1.73 m(2)) were identified between October 1, 2010 t
286 . mL-1; Control: 0.041 (0.035, 0.048) mug . min-1 . mL-1, P = 0.039] and infant cobalamin intake [Bo
287 n in milk [Bolus: 0.054 (0.047, 0.061) mug . min-1 . mL-1; Control: 0.041 (0.035, 0.048) mug . min-1
288 difference (95% CI): 4266 (261, 8270) mumol.min-1.kg-1.180 min; P = 0.04; eta2p = 0.31] and branched
289 tion of paraoxonase 1 (PON1) activity (mumol/min/mg) when compared with WT apoA-I and comparable PON1
291 C runtime was 3 min with retention times of (min); 0.63 (GA), 0.97 (RT), 2.00 (QT) and 2.41 (LT).
292 mpared to India, mean RR was 9.6 breaths per min higher in Guatemala, 12.1 breaths per min higher in
293 r min higher in Rwanda, and 16.1 breaths per min higher in Peru (likelihood ratio test p<0.0001).
294 er min higher in Guatemala, 12.1 breaths per min higher in Rwanda, and 16.1 breaths per min higher in
295 latin (area under the curve of 4.5 mg/mL per min administered intravenously) or cisplatin (70 mg/m(2)
296 lomerular filtration rate >=25 to <75 mL per min per 1.73 m(2), treated with optimized renin-angioten
297 e in 30 min, with an initial rate of 0.35 pH.min(-1) To understand the interplay in these composite s
300 volutionary correlations between P50 and psi(min) and between K(s) and Hv show signs of deeper evolut